Related Experiment Videos

[Clinical features and prognosis of decompensated hepatitis C virus related cirrhosis]

Chi-Hong Wu1, Geng-Shan Tian, Qin-Huan Wang

  • 1Department of Infectious Diseases, Peking University First Hospital, Beijing, China.

Zhonghua Yi Xue Za Zhi
|July 25, 2008
PubMed

Insights

Hepatitis C virus (HCV)-related cirrhosis complications significantly impact survival. Ascites is the most common initial decompensation, but hepatic encephalopathy carries the poorest prognosis, highlighting the need for close monitoring.

Area of Science:

  • Hepatology
  • Viral Hepatitis Research
  • Clinical Gastroenterology

Context:

  • Hepatitis C virus (HCV) infection is a leading cause of chronic liver disease and cirrhosis.
  • Cirrhosis progression can lead to decompensation events, affecting patient prognosis.
  • Understanding the clinical features and outcomes of decompensated HCV cirrhosis is crucial for patient management.

Purpose:

  • To investigate the clinical characteristics and survival outcomes of patients with hepatitis C virus (HCV)-related cirrhosis following their first decompensation event.
  • To identify factors influencing clinical decompensation in HCV-related cirrhosis.
  • To analyze the prognostic significance of different initial decompensation complications.

Summary:

  • This study analyzed 89 patients with decompensated HCV-related cirrhosis.
  • Ascites was the most frequent initial complication (44.9%), followed by upper gastrointestinal bleeding (23.6%), spontaneous peritonitis (20.2%), and hepatic encephalopathy (11.2%).
  • Multivariate analysis identified esophageal varices, gastroesophageal varices, and bilirubin levels as independent predictors of survival.

Impact:

  • The findings underscore that decompensation in HCV cirrhosis is strongly linked to survival.
  • Identifying high-risk complications like hepatic encephalopathy can guide clinical attention and potentially improve patient outcomes.
  • This research contributes to a better understanding of the long-term prognosis for patients with advanced HCV liver disease.
Abstract

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
208
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
171
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
457
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
355
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
303